Cortex Pharmaceuticals Inc.:

The Irvine drug company reported a net loss of $291,183, or 2 cents a share, for the first quarter ended Sept. 30, compared with a net loss of $1.2 million, or 12 cents a share, for the corresponding period last year. Research, license and grant revenue totaled $834,000. No revenue was recorded for the 1998 quarter.